FDA Hits Aesica Over Quality Controls, Record-Keeping Post author:Sam Post published:April 19, 2017 Post category:Drug Industry Daily The FDA has cited contract manufacturer Aesica for quality and record-keeping problems. Source: Drug Industry Daily You Might Also Like Homeopathic Drugmaker Violated Production Standards, FDA Says September 13, 2017 Novo Nordisk, Novartis Settle Patent Dispute Over Diabetes Blockbuster Victoza March 27, 2022 SCOTUS Denies Amgen’s Bid to Revive Repatha Patents May 18, 2023